Menu Back toThe-Metamorphosis-of-Clinical-Trials-Evolving-Roles-of-Stakeholders-in-Digital-Trials

DIA 2018 Global Annual Meeting


The Metamorphosis of Clinical Trials: Evolving Roles of Stakeholders in Digital Trials

    Session Chair(s)
      Josh  Rose, MBA

      Josh Rose, MBA

      • Vice President, Global Strategy and Innovation
      • IQVIA, United States
    This session will examine the promise of virtual trials to address challenges of traditional site-based models by examining the evolving roles of study stakeholders, patients, investigators, and study managers, and how they improve study performance
    Learning Objective : Describe the the potential promise, benefits, and considerations of virtual clinical trials to address challenges to clinical trial conduct and participation; Define the evolution of stakeholder roles, existing and new, and the interplay between them, in virtual/direct to patient clinical trials; Apply insights to inform virtual trial design and planning.